{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:48:06Z","timestamp":1791895686191,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013297","name":"Eurostars","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010444","name":"Canton of Vaud General Directorate of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002784","name":"Canada Excellence Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116472","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:20:37Z","timestamp":1711326037000},"page":"116472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A next generation peripherally restricted Cav\u03b12\u03b4-1 ligand with inhibitory action on Cav2.2 channels and utility in neuropathic pain"],"prefix":"10.1016","volume":"174","author":[{"given":"Franz","family":"Kricek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premji","family":"Meghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana A.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Skouteris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.biopha.2024.116472_bib1","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1113\/JP272262","article-title":"Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology","volume":"59","author":"Dolphin","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2024.116472_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbamem.2012.11.019","article-title":"The \u03b12\u03b4 subunits of voltage-gated calcium channel","volume":"1828","author":"Dolphin","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2024.116472_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2015.5","article-title":"Targeting voltage-gated calcium channels in neurological and psychiatric diseases","volume":"15","author":"Zamponi","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.biopha.2024.116472_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.biopha.2024.116472_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor alpha2 delta-1 Is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.116472_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/srep24531","article-title":"Thrombospondin-4 reduces binding affinity of [(3)H]-gabapentin tocalcium-channel a2d-11subunit but does not interact with a2d-1 on the cellsurface when co-expressed","volume":"6","author":"Lana","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116472_bib7","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001","article-title":"Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats","volume":"21","author":"Luo","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2024.116472_bib8","doi-asserted-by":"crossref","first-page":"8494","DOI":"10.1523\/JNEUROSCI.2982-04.2004","article-title":"Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia","volume":"24","author":"Li","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2024.116472_bib9","doi-asserted-by":"crossref","first-page":"H117","DOI":"10.1152\/ajpheart.00122.2009","article-title":"Targeted disruption of the voltage-dependent calcium channel a2d1 subunit","volume":"297","author":"Fuller-Bicer","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2024.116472_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pain.2006.04.022","article-title":"Calcium channel alpha(2)delta(1) subunit mediates spinal hyperexcitability in pain modulation","volume":"125","author":"Li","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2024.116472_bib11","doi-asserted-by":"crossref","first-page":"16412","DOI":"10.1523\/JNEUROSCI.1026-13.2013","article-title":"\u03b12\u03b4-1 Gene Deletion Affects Somatosensory Neuron Function and Delays Mechanical Hypersensitivity in Response to Peripheral Nerve Damage","volume":"33","author":"Patel","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2024.116472_bib12","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.0409066103","article-title":"Identification of the \u03b12\u03b4-1 subunit of voltage-dependent calcium channels as a novel molecular target for pain mediating the analgesic actions of pregabalin","volume":"103","author":"Field","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2024.116472_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.205","article-title":"Mechanisms of the gabapentinoids and a2d-1 calcium channel subunit in neuropathic pain. s","volume":"4","author":"Patel","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.biopha.2024.116472_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res"},{"issue":"13","key":"10.1016\/j.biopha.2024.116472_bib15","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0356-09.2009","article-title":"The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin","volume":"29","author":"Bauer","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2024.116472_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fncel.2020.00083","article-title":"Pregabalin as a Pain Therapeutic: Beyond Calcium Channels","volume":"14","author":"Alles","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"3 Suppl","key":"10.1016\/j.biopha.2024.116472_bib17","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85","author":"Dworkin","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.biopha.2024.116472_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023600","article-title":"Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials","volume":"9","author":"Onakpoya","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.biopha.2024.116472_bib19","article-title":"Gamma aminobutyric acid analogues for the treatment of pain and other disorders","volume":"9","author":"Meghani","year":"2018","journal-title":"US Pat. No"},{"key":"10.1016\/j.biopha.2024.116472_bib20","unstructured":"Ford R.L. &Meghani P.M. Separation of enantiomers of 3-ethylbicyclo[3.2.0]HEPT 3-EN-6-One (2019) US Patent No 10,150, 723 B2."},{"key":"10.1016\/j.biopha.2024.116472_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennet","year":"1988","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.biopha.2024.116472_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.biopha.2024.116472_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(99)00111-6","article-title":"Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones?","volume":"83","author":"Field","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2024.116472_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.biopha.2024.116472_bib25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/1087057112452318","article-title":"Kinetic Considerations on the Development of Binding Assays in Single-Addition Mode: Application to the Search for \u03b12\u03b41 Modulators","volume":"17","author":"Calvo","year":"2012","journal-title":"J. Biomol. Screen"},{"issue":"4","key":"10.1016\/j.biopha.2024.116472_bib26","first-page":"396","article-title":"Whole-cell patch-clamp recording of recombinant voltage-sensitive Ca2+ channels heterologously expressed in HEK-293 cells","author":"Gandini","year":"2014","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.biopha.2024.116472_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/bj3420313","article-title":"Structural requirement of the calcium-channel subunit a2d for gabapentin binding","volume":"342","author":"Wang","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2024.116472_bib28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41594-023-00951-7","article-title":"Structural basis for CaV\u03b12\u03b4:gabapentin binding","volume":"30","author":"Chen z.","year":"2023","journal-title":"Nature Structural & Molecular Biology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116472_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/chan.2.1.6045","article-title":"Time course and specificity of the pharmacological disruption of the trafficking of voltage\u2011gated calcium channels by gabapentin","volume":"2","author":"Heblich","year":"2008","journal-title":"Channels"},{"issue":"9","key":"10.1016\/j.biopha.2024.116472_bib30","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1073\/pnas.0708930105","article-title":"Pharmacological disruption of calcium channel trafficking by the \u03b12\u03b4-1 ligand gabapentin","volume":"105","author":"HendrichJ","year":"2008","journal-title":"Proc. Natl. Acad. Sci.\u00a0USA"},{"key":"10.1016\/j.biopha.2024.116472_bib31","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.bmcl.2005.05.016","article-title":"Carboxylate bioisosteres of gabapentin","volume":"16","author":"Burgos-Lepleya","year":"2006","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.biopha.2024.116472_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bmcl.2008.10.101","article-title":"Oxadiazolone bioisosteres of pregabalin and gabapentin","volume":"19","author":"Wustrow","year":"2009","journal-title":"Bioorg. Med Chem. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2024.116472_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2042098613505614","article-title":"Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain","volume":"5","author":"Toth","year":"2014","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.biopha.2024.116472_bib34","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/jpet.104.082255","article-title":"Mediation of highly concentrative uptake of pregabalin by L Type amino acid transport in chinese hamster ovary and caco-2 cells","volume":"313","author":"Su","year":"2005","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2024.116472_bib35","article-title":"Cloning and deletion mutagenesis of the alpha2 delta calcium channel subunit from porcine cerebral cortex","volume":"273","author":"Brown","year":"1998"},{"key":"10.1016\/j.biopha.2024.116472_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.biopha.2024.116472_bib37","series-title":"Proceedings of The10th Congress on Pain","first-page":"489","article-title":"Predictive validity of neuropathic pain models in pharmacological studies with a behavioral outcome in the rat: A systematic review","author":"Kontinen","year":"2003"},{"issue":"3","key":"10.1016\/j.biopha.2024.116472_bib38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/jpet.117.247551","article-title":"Binding characteristics and analgesic effects of mirogabalin, a novel ligand for the \u03b12\u03b4 subunit of voltage-gated calcium channels","volume":"365","author":"Domon","year":"2018","journal-title":"J. Pharm. Exp. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2024.116472_bib39","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2337\/dc14-1044","volume":"37","author":"Vinik","year":"2014","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.biopha.2024.116472_bib40","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.celrep.2018.02.021","article-title":"The \u03b12\u03b4-1-NMDA receptor complex is critically involved in neuropathic pain development and gabapentin therapeutic actions","volume":"22","author":"Chen","year":"2018","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.biopha.2024.116472_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.01.073","article-title":"BK potassium channels suppress Cav\u03b12\u03b4 subunit function to reduce inflammatory and neuropathic pain","volume":"22","author":"Zhang","year":"2018","journal-title":"Cell Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T22:59:12Z","timestamp":1782341952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224003561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":41,"alternative-id":["S0753332224003561"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116472","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A next generation peripherally restricted Cav\u03b12\u03b4-1 ligand with inhibitory action on Cav2.2 channels and utility in neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Novassay SA. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116472"}}